These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 30610059)

  • 1. SUV39H1 Represses the Expression of Cytotoxic T-Lymphocyte Effector Genes to Promote Colon Tumor Immune Evasion.
    Lu C; Yang D; Klement JD; Oh IK; Savage NM; Waller JL; Colby AH; Grinstaff MW; Oberlies NH; Pearce CJ; Xie Z; Kulp SK; Coss CC; Phelps MA; Albers T; Lebedyeva IO; Liu K
    Cancer Immunol Res; 2019 Mar; 7(3):414-427. PubMed ID: 30610059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SUV39H1 regulates human colon carcinoma apoptosis and cell cycle to promote tumor growth.
    Lu C; Klement JD; Yang D; Albers T; Lebedyeva IO; Waller JL; Liu K
    Cancer Lett; 2020 Apr; 476():87-96. PubMed ID: 32061753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H3K9 Trimethylation Silences Fas Expression To Confer Colon Carcinoma Immune Escape and 5-Fluorouracil Chemoresistance.
    Paschall AV; Yang D; Lu C; Choi JH; Li X; Liu F; Figueroa M; Oberlies NH; Pearce C; Bollag WB; Nayak-Kapoor A; Liu K
    J Immunol; 2015 Aug; 195(4):1868-82. PubMed ID: 26136424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8
    Farhood B; Najafi M; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas.
    Niborski LL; Gueguen P; Ye M; Thiolat A; Ramos RN; Caudana P; Denizeau J; Colombeau L; Rodriguez R; Goudot C; Luccarini JM; Soudé A; Bournique B; Broqua P; Pace L; Baulande S; Sedlik C; Quivy JP; Almouzni G; Cohen JL; Zueva E; Waterfall JJ; Amigorena S; Piaggio E
    Nat Commun; 2022 Jun; 13(1):3739. PubMed ID: 35768432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma.
    Chiba T; Saito T; Yuki K; Zen Y; Koide S; Kanogawa N; Motoyama T; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Otsuka M; Miyazaki M; Iwama A; Yokosuka O
    Int J Cancer; 2015 Jan; 136(2):289-98. PubMed ID: 24844570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p50 suppresses cytotoxic T lymphocyte effector function to regulate tumor immune escape and response to immunotherapy.
    Lu C; Klement JD; Smith AD; Yang D; Waller JL; Browning DD; Munn DH; Liu K
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33051343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of Proprotein Convertases in T Cells Inhibits PD-1 Expression and Creates a Favorable Immune Microenvironment in Colorectal Cancer.
    Tomé M; Pappalardo A; Soulet F; López JJ; Olaizola J; Leger Y; Dubreuil M; Mouchard A; Fessart D; Delom F; Pitard V; Bechade D; Fonck M; Rosado JA; Ghiringhelli F; Déchanet-Merville J; Soubeyran I; Siegfried G; Evrard S; Khatib AM
    Cancer Res; 2019 Oct; 79(19):5008-5021. PubMed ID: 31358531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asah2 Represses the p53-Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis.
    Zhu H; Klement JD; Lu C; Redd PS; Yang D; Smith AD; Poschel DB; Zou J; Liu D; Wang PG; Ostrov D; Coant N; Hannun YA; Colby AH; Grinstaff MW; Liu K
    J Immunol; 2021 Mar; 206(6):1395-1404. PubMed ID: 33547170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints.
    Llosa NJ; Cruise M; Tam A; Wicks EC; Hechenbleikner EM; Taube JM; Blosser RL; Fan H; Wang H; Luber BS; Zhang M; Papadopoulos N; Kinzler KW; Vogelstein B; Sears CL; Anders RA; Pardoll DM; Housseau F
    Cancer Discov; 2015 Jan; 5(1):43-51. PubMed ID: 25358689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of murine tumour growth through CD8
    Kogo H; Shimizu M; Negishi Y; Uchida E; Takahashi H
    Immunology; 2017 Jul; 151(3):324-339. PubMed ID: 28294313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G6PD functions as a metabolic checkpoint to regulate granzyme B expression in tumor-specific cytotoxic T lymphocytes.
    Lu C; Yang D; Klement JD; Colson YL; Oberlies NH; Pearce CJ; Colby AH; Grinstaff MW; Ding HF; Shi H; Liu K
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35017152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PGC-1α activator-induced fatty acid oxidation in tumor-infiltrating CTLs enhances effects of PD-1 blockade therapy in lung cancer.
    Wan H; Xu B; Zhu N; Ren B
    Tumori; 2020 Feb; 106(1):55-63. PubMed ID: 31451071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving function of cytotoxic T-lymphocytes by transforming growth factor-β inhibitor in oral squamous cell carcinoma.
    Kondo Y; Suzuki S; Takahara T; Ono S; Goto M; Miyabe S; Sugita Y; Ogawa T; Ito H; Satou A; Tsuzuki T; Yoshikawa K; Ueda R; Nagao T
    Cancer Sci; 2021 Oct; 112(10):4037-4049. PubMed ID: 34309966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolyl isomerase Pin1 negatively regulates the stability of SUV39H1 to promote tumorigenesis in breast cancer.
    Khanal P; Kim G; Lim SC; Yun HJ; Lee KY; Choi HK; Choi HS
    FASEB J; 2013 Nov; 27(11):4606-18. PubMed ID: 23934277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone methyltransferase Suv39h1 attenuates high glucose-induced fibronectin and p21(WAF1) in mesangial cells.
    Lin SH; Ho WT; Wang YT; Chuang CT; Chuang LY; Guh JY
    Int J Biochem Cell Biol; 2016 Sep; 78():96-105. PubMed ID: 27373678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Domatinostat favors the immunotherapy response by modulating the tumor immune microenvironment (TIME).
    Bretz AC; Parnitzke U; Kronthaler K; Dreker T; Bartz R; Hermann F; Ammendola A; Wulff T; Hamm S
    J Immunother Cancer; 2019 Nov; 7(1):294. PubMed ID: 31703604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models.
    Jing W; McAllister D; Vonderhaar EP; Palen K; Riese MJ; Gershan J; Johnson BD; Dwinell MB
    J Immunother Cancer; 2019 Apr; 7(1):115. PubMed ID: 31036082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation.
    Vaquero A; Scher M; Erdjument-Bromage H; Tempst P; Serrano L; Reinberg D
    Nature; 2007 Nov; 450(7168):440-4. PubMed ID: 18004385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel co-culture assay to assess anti-tumor CD8
    Olivo Pimentel V; Yaromina A; Marcus D; Dubois LJ; Lambin P
    J Immunol Methods; 2020 Dec; 487():112899. PubMed ID: 33068606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.